(Tromsø 01. June 2017) Børge Sørvoll, CFO of Biotec Pharmacon has today
purchased 5 474 shares in Biotec Pharmacon at NOK 5.85 per share. After this
transaction holds Sørvoll 11.690 shares and 82.500 options in Biotec Pharmacon
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.
For further information, please contact
Børge Sørvoll
CFO
+47 952 90 187
borge.sorvoll@biotec.no